Nu Skin (NUS) just unveiled an announcement.
Nu Skin Enterprises, Inc. stockholders showed strong support at their 2024 Annual Meeting by backing key proposals, including the adoption of the 2024 Omnibus Incentive Plan, which replaces the previous 2010 plan. This new plan allows for various types of awards to employees and consultants and will be in effect until 2034. Additionally, the election of eight directors, the executive compensation package, and the ratification of PricewaterhouseCoopers LLP as the company’s independent auditor for the year received affirmative votes, reflecting shareholder confidence in the company’s governance and strategic direction.
Learn more about NUS stock on TipRanks’ Stock Analysis page.
